Evidence map›Paper›PMID 39176020›Full record

ArticleActa radiologica open2024

To biopsy or not to biopsy adrenal mass: is that the question?

Edouard Purenne, Erika Cornu, Vincent Mezzarobba, Pauline Juttet, Sébastien Cimarelli, Emmanuel Watkin, Anne-Cécile Paepegaey

Abstract readCase Reports
In one paragraph

Article in Acta radiologica open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edouard PurenneDepartment of Radiology, Medipole, Lyon-Villeurbanne, Villeurbanne, France.
Erika CornuDepartment of Endocrinology, Medipole, Lyon-Villeurbanne, Villeurbanne, France.
Vincent MezzarobbaDepartment of Endocrinology, Medipole, Lyon-Villeurbanne, Villeurbanne, France.
Pauline JuttetDepartment of Endocrinology, Medipole, Lyon-Villeurbanne, Villeurbanne, France.
Sébastien CimarelliDepartment of Nuclear Medicine, IMHOTEP, Villeurbanne, France.
Emmanuel WatkinDepartment of Pathology, CYPATH, Villeurbanne, France.
Anne-Cécile PaepegaeyDepartment of Endocrinology, Medipole, Lyon-Villeurbanne, Villeurbanne, France.ORCID https://orcid.org/0000-0003-4250-5771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Society of Endocrinology recommends surgical approach for suspicious adrenal mass with a limited role for adrenal biopsy. We report here a case of a patient with a 70 mm adrenal mass in whom adrenal biopsy avoided unnecessary adrenalectomy. An 80-year-old man was explored for a 67 × 41 mm suspect left adrenal tumor. Hormonal explorations were normal. 18F-FDG-PET/CT showed an increase in uptake of the adrenal mass (SUVmax: 44.6). As the diagnostic was uncertain, biopsy was performed. Pathology found T lymphocytic inflammatory infiltrate with CD4 phenotype without malignancy criteria. Simple close monitoring was decided in multidisciplinary meeting and with the patient's consent. At 1 and 3 months, CT and 18F-FDG-PET/CT showed a significant decrease in size and uptake of adrenal mass (40 × 20 mm and 19 × 10 mm and SUVmax 5.9 and 0.0). This report shows the interest of adrenal biopsy for well-selected cases to avoid unnecessary adrenal surgery.

Indexed as

adrenal biopsyadrenal tumorcase reportinflammatory infiltratepseudotumoral adrenal mass

Identifiers

PMID39176020
PMCPMC11339733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.